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Objective: To assess the effectiveness of a functional splint 
for trapeziometacarpal osteoarthritis. 
Methods: Forty patients with a diagnosis of painful trapezio­
metacarpal osteoarthritis of the dominant hand were rando­
mized into 2 groups. The study group received the splint at 
baseline and used it during activities of daily living for 180 
days and the control group used the splint only during the 
evaluations for the first 90 days and during activities of daily 
living for the following 90 days. Pain, strength, hand func­
tion and dexterity (with and without splint) were measured 
by a blinded assessor at baseline, 45, 90 and 180 days.
Results: The groups were homogenous at baseline for all out­
comes evaluated. Pain without the splint was significantly 
different between groups over time; the study group experi­
enced a decrease in pain beginning with the first evaluation 
(45 days), whereas the control group achieved a lower pain 
score only at the end of the study, after having used the splint 
for 90 days. No significant differences between groups were 
found for the other parameters. 
Conclusion: Splint use during activities of daily living for pa­
tients with trapeziometacarpal osteoarthritis reduces pain, 
but does not alter function, grip strength, pinch strength or 
dexterity.
Key words: functional splint; trapeziometacarpal joint; osteoar-
thritis; pain; function.
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INTRODUCTION
Osteoarthritis (OA) is one of the most common joint diseases. 
It affects approximately 12% of the population over 65 years 
in the USA (1,2). In Brazil it affects between 6% and 12% of 
adult population (3). The incidence is lower among individu-
als under the age of 40 years and increases progressively. OA 
is more common between 51 and 60 years of age and is more 
symptomatic among post-menopausal females (1, 4).
The prevalence of OA of the hand varies widely. A prospec-
tive cohort study did in the Netherlands, based on radiographic 
data shows that 67% of women and 54.8% of men may have 
one joint affected. The most commonly affected sites are the 
distal interphalangeal joints (47.3%), trapeziometacarpal 
(TMC) joint (35.8%), proximal interphalangeal joints (18.2%) 
and metacarpophalangeal joints (MCP) (8.2%) (5).
Patients with OA of the hand normally experience a loss of 
manual ability and grip strength, especially when the TMC 
joint is affected (6–9). The TMC joint has 2 main functional 
characteristics: freedom of movement and stability (10, 11). It 
is considered one of the most important hand joints, as 45% of 
hand function results from the action of the thumb (12).
One of the primary factors in OA of the TMC joint is believed 
to be the inherent laxity of the volar oblique ligament. When 
this joint is repeatedly stressed, subluxation occurs, resulting 
in incongruity of opposing surfaces, inflammation and eventual 
degeneration. These joint changes cause stiffness, which is often 
increased by the formation of osteophytes in the trapezium or 
metacarpal base. Movement can be further limited if the TMC 
joint becomes fixed in a dorsally subluxed position, limiting 
radial adduction. The thumb metacarpophalangeal joint may 
become hyperextended in an effort to compensate (13).
The main symptoms of OA of the TMC joint are pain in the 
dorsoradial and volar face of the hand on the projection of 
the angle formed by the index finger and thumb in abduction, 
and loss of grip strength. The aims of conservative treatment 
include the preservation of the first interdigital space, pain 
relief, maintenance of thumb function, orientation regarding 
joint protection, energy conservation and the use of adapta-
tions. In the rehabilitation process, splints are a therapeutic 
resource that provide patients with the opportunity to achieve 
their maximum recovery potential (14–17).
Conservative treatment of OA of the TMC includes analge-
sics, joint protection, strengthening exercises of the intrinsic 
and extrinsic muscles of the thumb, assistive devices and 
splints. Surgical management may be recommended to re-
lieve intractable pain. The procedure used varies according 
to disease stage (13).
Splints for OA of the TMC provide external support to the joint, 
thereby stabilizing the adjacent joints capable of compensatory 
movements and maintaining the first joint space (18, 19). The 
literature on splints for OA of the TMC is scarce, but a number 
of authors report that many rheumatologists recommend their use, 
although they do not publish studies on the subject (20). A pro-
spective study that examined the effectiveness of steroid injection 
in combination with splinting found that this kind of treatment 
provided reliable long-term relief to the thumb (21). 
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A randomized controlled trial (RCT) comparing 2 6-week 
splint and exercise regimens for patients with trapeziometacar-
pal OA found that both groups improved; however, no differ-
ences were found between groups regarding pain, strength or 
hand function (22). Another RCT comparing a custom-made 
neoprene splint and usual care found that the splint had no 
effect on pain at 1 month, but improved pain and disability at 
12 months; however, the splint was a rigid rest splint recom-
mended for use only at night and the assessor was not blinded 
(23). Another RCT comparing a joint protection programme 
alone and joint protection programme with the addition of day/
night splints and hot pack/home exercise found that when an 
exercise regimen and a splint are added to a joint protection 
programme, there is a greater improvement in pain, stiffness, 
grip strength and performance on activities of daily living in 
comparison with the joint protection programme alone (24).
A review published in 2007 concluded that, although evidence 
regarding the effectiveness of splinting for carpometacarpal OA 
is underdeveloped, the research to date indicates that splinting 
may help relieve pain. Further investigation is recommended 
using a controlled methodology, more thorough reporting of 
outcomes and tracking of analgesic use. Given the conservative 
nature and relatively low cost of splinting, it is recommended 
that patients be given the opportunity to try a splint (25).
The aim of the present study was to assess the effectiveness 
of a functional splint for the thumb of the dominant hand of 
patients with Grade II and III OA of the TMC joint. 
METHODS
Forty patients with a diagnosis of OA of the TMC joint of the dominant 
hand were randomized into 2 groups of 20 individuals. Eligibility 
criteria were: a clinical and radiological diagnosis of idiopathic Grade 
II and III OA of the TMC joint of the dominant hand; (26) either 
gender; over 40 years of age; and pain in the base of the thumb of the 
dominant hand of between 3 and 7 on the 0–10 cm visual analogue 
scale (VAS) for pain. 
Exclusion criteria were patients with severe deformities of the domi-
nant hand that did not allow gripping between the first, second and third 
fingers; deformities of the distal interphalangeal joint; the use of a splint 
on the thumb in the previous 6 months; surgery on the hand under study 
in the previous 6 months or scheduled in the upcoming 6 months; allergy 
to the splint material; incapacity to respond to the questionnaire and 
perform the tests; geographical inaccessibility; injections in the hand 
under study in the previous 6 months; other associated diseases such 
as carpal tunnel syndrome, fractures in the carpus, tendonitis, chronic 
inflammatory arthropathy and alterations in the use of anti-inflammatory 
medication and analgesics in the previous 3 months.
The present study was approved by the ethics committee. All patients 
signed terms of informed consent and were randomly allocated to 2 
groups of 20 patients: splint group (SG) and control group (CG). A 
computer-generated randomization list was used to randomly allocate 
patients into the groups and concealed allocation was carried out with 
opaque sealed envelope. 
This trial was registered at clinicaltrials.gov (ID: NCT00612248).
Intervention
An occupational therapist (ACGC) specialized in rheumatology with 
10 years experience confected a functional thermoplastic splint for the 
participants of both groups, the aim of which was to stabilize the TMC 
joint, maintaining the pulp of the distal phalange of the index finger free 
for gripping with the other fingers and leaving the thumb in a functional 
position (Fig. 1) (18). Patients in the SG received the splint on the day 
of the first evaluation and took it with them for use during activities of 
daily living, including paid or unpaid work. They were instructed to 
remove it during rest (sleeping), bathing and activities in which they 
had contact with heat. They were also instructed as to how to put the 
splint on and cleaning procedures. In cases of discomfort regarding 
the use of the splint, patients were instructed to communicate with the 
therapist in order to perform the necessary adjustments.
Patients in the CG initially used the splint only during the evalua-
tions. The splints remained in the possession of the researcher and were 
only given to patients for home use after the third evaluation (T90). 
Patients of the CG used the splint daily between T90 and T180.
Evaluations
Evaluations were carried out by a blinded assessor at baseline (T0), 
after 45 days (T45), after 90 days (T90) and after 180 days (T180). All 
evaluations were performed by a physiotherapist trained to administer 
the tests. At the beginning of each evaluation the occupational thera-
pist in charge of the study inspected the splints of the patients in the 
SG and gave the splints to the patients in the CG so that all patients 
saw the assessor wearing their splints. Patients were instructed not to 
comment to the evaluator regarding the use of the splint.
The primary outcome was:
• Pain in the base of the thumb – a VAS from 0 to 10 cm was used, 
for which 0 represents no pain and 10 represents unbearable pain. 
The patient indicated his/her level of pain on the scale using the tip 
of a pen. Pain was assessed in 2 stages:
• Pain without the splint – average pain the patient felt in the previ-
ous week without the use of the splint;
• Pain with the splint – average pain the patient felt using the splint 
during the evaluation.
The secondary outcomes were:
• Functional capacity – the Disabilities of the Arm, Shoulder and Hand 
(DASH) questionnaire was used. This instrument is composed of 30 
questions measuring function and symptoms. It includes 2 items on 
physical function, 6 items on symptoms and 3 items on social aspects 
(Q3). There are also 2 optional modules with 4 items each –one for 
athletes and musicians (Q1) and another for workers (Q2). All items 
were answered based on the patient’s experiences in the previous 
week. If the patient did not have the opportunity to perform one of 
the activities in the previous week, he or she was asked to estimate 
the most accurate response. The score ranges from 0 to 96 points, 
for which higher scores represent worse functional capacity (27).
• Grip strength – the Jamar dynamometer was used. The test was car-
ried out of the dominant hand with and without the splint. Patients 
were seated with the elbow at 90 degrees of flexion and the wrist in 
a neutral position between pronation and supination. The dynamo-
meter was set at number 2, in accordance with the instruction manual 
(PC-5030J1 – Preston/Trenton, Ontario Canada; Mathiowetz, 1984). 
Measurements were taken in Kgf, from which the mean result was 
considered for analysis. Participants were verbally encouraged to 
make an effort during all measurements.
• Pinch strength – a pinch gauge dynamometer was used. The test was 
performed with the dominant hand both with and without the splint. 
Patients were in the same position as in the grip strength test. Three 
Fig. 1. Model of confected splint.
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measures were taken for each pinch (tip and key pinch), for which 
the mean in Kgf was considered in the analysis, in accordance with 
the instruction manual for the equipment (A853-4-Smith & Nephew/
Germantown, USA, Mathiowetz, 1984). Participants were verbally 
encouraged to make an effort during all measurements.
• Upper limb dexterity – the O’Connor test equipment was used 
(Lafayette Instrument®, USA). Dexterity in the O’Connor test is 
defined as the time it takes to place three pins in one hole on five 
rows of the board. Patients performed the test while seated and the 
board was placed on a table in front of them. Patients were allowed 
to make a practice run in order to become familiar with the test, 
following the manufacturer’s instructions. The performance time 
was recorded in seconds using a chronometer from the first to fifth 
row (1st time) and then from the sixth to tenth row (2nd time). Both 
times were used for the calculation of the final score.
Statistical analysis 
A minimum of 17 patients per group were needed in order to identify 
a 2-cm improvement in the VAS for pain with a 0.05 alpha and 0.20 
beta. Forty patients were randomized in order to compensate for a 
possible loss of 20%. The significance level was set at p < 0.05. All 
tests were performed using the SPSS version 10 (SPSS, Chicago, IL, 
USA) and intention-to-treat analysis was carried out when necessary. 
Pearson’s χ2 and Fisher’s exact tests were employed to determine the 
homogeneity of the sample. Categorical variables were analysed using 
the Mann-Whitney test. 
The data were analysed in 2 stages:
• Period A – comparison between groups over time – between T0 and 
T90.
• Period B – comparison between groups over time – between T0 and 
T180. 
For data with normal distribution in periods A and B, analysis of 
variance (ANOVA) for repeated measurements was used to determine 
differences in the behaviour of the groups over time considering the 
existing relationship between evaluations of a single individual. When a 
statistically significant difference over time was found between groups, 
the Mann-Whitney or t-tests were used to analyse differences at each 
time. Analysis of the VAS for pain score with the use of the splint was 
performed at T45, T90 and T180 using an independent-sample t-test, as 
both groups were only assessed for this parameter beginning at T45, at 
which point the difference was already evident. Pain, strength and dexter-
ity parameters with and without the use of the splint were compared in 
both the SG and CG at each assessment time using a paired t-test. 
RESULTS
The groups were homogenous at baseline with regard to age, 
disease duration, gender, degree of OA of the TMC, domi-
nance, race and profession. Median age was 65.5 years in the 
control group and 64.8 years in the study group. There was a 
predominance of female subjects, which is similar to the preva-
lence of the disease (4, 7). All 40 patients who began the study 
completed all the evaluations; no patient was lost throughout 
the study period. Fig. 2 shows the patient flow-chart for each 
step of the study. Table I displays the sample characteristics 
with regard to age, disease duration, gender, ethnicity, level 
of schooling, profession, pain, DASH, grip strength, pinch 
strength and dexterity on the initial evaluation.
Period A – analysis between T0 and T90
A reduction in the VAS for pain without the splint was observed 
in the SG, whereas pain remained constant in the CG. This dif-
ference was statistically significant between groups (p = 0.003) 
(Table II) and was observed at T45 and T90 (p = 0.013 and 
p = 0.002, respectively). In the intra-group comparison, pain 
reduced in the SG significantly in T0/T45 (p < 0.001) and T0/




(n = 20) p
Age, years, mean (SD) 62.8 (8.5) 65.1 (10.1) 0.665
Duration of disease, years,  
mean (SD)
6.3 (3.4) 7.7 (6.1) 0.503
Gender, female/male, n 20/0 18/2 0.147
Degree disease, II/III, n 19/1 20/0 0.311
Ethnicity, white/non-white, n 13/7 14/6 0.736
Hand dominance, right/left, n 19/1 20/0 0.311
Pain – VAS, cm, mean (SD)
without splint 5.1 ( 1.4) 5.1 (1.1) 0.978
Grip strength (Kgf – mean (SD))
with splint 18.1 (8.8) 20.2 (7.3) 0.185
without splint 18.7 (6.8) 20.5 (7.7) 0.409
Pinch strength – key, Kgf, mean (SD)
with splint 4.6 (1.5) 4.9 (1.5) 0.413
without splint 5.4 (1.9) 5.2 (1.7) 0.625
Pinch strength – tip, Kgf, mean (SD)
with splint 3.5 (1.3) 3.4 (1.2) 0.775
without splint 3.3 (1.2) 3.1 (0.9) 0.303
Dexterity, s, mean (SD) 
with splint 334.2 (57.4) 333.8 (66.5) 0.871
without splint 357.4 (76.0) 359.3 (81.6) 0.766
Hand function – DASH, mean (SD)
Question 1 2.8 (12.6) 1.6 (5.7) 0.594
Question 2 15.0 (20.4) 22.8 (28.0) 0.383
Question 3 42.0 (18.4) 39.1 (16.9) 0.655
SG: study group; CG: control group; VAS: visual analogue scale; 
DASH: Disabilities of the Arm, Shoulder and Hand questionnaire; Kgf: 
kilogram force.
Fig. 2. Participants in each stage of the trial.  
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T90 (p < 0.001), demonstrating that the reduction in pain oc-
curred in the first 45 days of treatment and was maintained for 
another 45 days (T90).
There were no significant differences between groups over 
time regarding the Q1 and Q2 scores of the DASH (p = 0.524 
and p = 0.893, respectively). Both groups had a reduction in 
Q3 scores (p = 0.382). Regarding dexterity, grip and pinch 
strength with and without the splint, there were no significant 
intra-group differences over time (Table II).
Period B – analysis between T90 and T180
In the comparison between groups from T0 and T180, there 
was only a statistically significant difference in pain without 
the splint. The significant difference between groups from T0 
to T90 regarding pain without the splint remained significant 
between T0 and T180 (p = 0.009). This demonstrates that, 
despite the improvement in the CG after using the splint for 
90 days during activities of daily living, this improvement 
did not match that of the SG at the end of the study, which 
clearly demonstrates the benefit of the splint regarding pain. 
This benefit was already clear by T90 and the improvement in 
this parameter continued, demonstrating an additional gain for 
the SG regarding pain without the splint through to T180. No 
statistically significant differences between groups were found 
in Period B for the DASH, strength or dexterity (Table II). 
VAS for pain with the splint
There was a statistically significant difference between groups 
regarding pain during the use of the splint (p < 0.001 at T45; 
p = 0.001 at T90; and p = 0.026 at T180). 
Intra-group comparisons with and without the splint regarding 
pain, strength and dexterity
In the SG, a statistically significant difference was found for key pinch 
strength at T90 (p = 0.022) and T180 (p = 0.018), in which strength 
with the splint was lower than without the splint. Regarding dexterity, 
the test was performed slower with the splint than without the splint 
at T0 (p = 0.011). Pain scores were lower during the use of the splint 
(p = 0.038 at T45 and p = 0.009 at T90) (Table III).
In the CG, a statistically significant difference was found 
for key pinch strength for all the evaluations (p = 0.003 at T0, 
p = 0.004 at T45, p = 0.011 at T90 and p = 0.026 at T180), with 
strength always lower during the performance of the test with 
the splint. Regarding dexterity, the test was performed slower 
without the splint at T0 (p = 0.014). Pain scores were lower 
during the use of the splint at T180 (p = 0.039) (Table III).
DISCUSSION
The aim of the present study was to assess the effectiveness of a 
splint for OA of the TMC. The main parameter was pain reported 
by patients with and without the use of the splint, as pain is one of 
the reasons for dysfunction in manual abilities and the seeking of 
medical care. Together with deformities, pain can cause disability 
and dependence in activities of daily living. The participants in 
the study also complained of difficulty in performing daily tasks, 
correlating this difficulty to pain in the TMC joint. 
The use of a splint during activities of daily living reduced 
pain in patients with OA of the TMC joint. Both groups showed 
improvement – the improvement in the SG occurred early in 
the study, whereas improvement in the CG occurred after T90, 
when this group also began using the splint during activities of 
Table II. Inter-group comparison of hand pain (VAS), functional capacity, grip strength, pinch strength and dexterity
T0 T45 T90 T180
CG SG CG SG CG SG p1 CG SG p3
Pain (VAS – cm)
without splint 5.1 (1.4) 5.1 (1.1) 4.8 (1.9) 3.1 (2.1) 5.2 (2.0) 2.9 (2.2) 0.003* 4.4 (2.5) 2.5 (2.6) 0.009*
p2 0.950 0.013* 0.002* 0.023*
with splint – – 4.8 (2.6) 2.1 (1.6) 4.3 (2.2) 1.9 (1.9) 0.680 3.4 (2.6) 1.7 (2.1) –
p2 < 0.001* 0.001* 0.026*
Grip strength, Kgf
without splint 18.7 (6.8) 20.5 (7.7) 18.3 (6.9) 21.6 (5.8) 20.1 (6.1) 20.9 (6.4) 0.311 20.1 (5.2) 20.8 (5.3) 0.207
with splint 18.08 (8.8) 20.18 (7.3) 18.3 (6.8) 22.4 (5.5) 19.5 (7.6) 22.1 (7.2) 0.150 20.2 (7.1) 22.3 (5.6) 0.217
Pinch strength – key, Kgf
without splint 5.4 (1.9) 5.2 (1.7) 5.5 (1.8) 5.7 (1.4) 5.7 (1.8) 5.9 (1.6) 0.360 5.7 (1.7) 6.0 (1.7) 0.882
with splint 4.6 (1.5) 4.9 (1.5) 4.9 (1.3) 5.4 (1.2) 5.2 (1.6) 5.4 (1.7) 0.742 5.3 (1.5) 5.5 (1.6) 0.540
Pinch strength – tip, Kgf
without splint 3.3 (1.2) 3.1 (0.9) 3.3 (1.2) 3.7 (0.9) 3.7 (1.1) 3.8 (1.1) 0.322 4.4 (1.3) 4.1 (0.9) 0.118
with splint 3.5 (1.3) 3.4 (1.2) 3.5 (1.3) 3.9 (0.8) 3.9 (1.2) 4.1 (1.2) 0.176 4.3 (1.0) 4.3 (0.8) 0.373
Dexterity, s
without splint 357.4 (76.0) 359.3 (81.6) 356.5 (146.5) 330.8 (94.4) 341.4 (117.1) 309.5 (89.2) 0.255 321.7 (67.7) 295.7 (80.5) 0.316
with splint 334.1 (57.4) 333.8 (66.5) 376.1 (157.1) 318.1 (70.7) 335.0 (97.8) 295.4 (59.9) 0.092 324.6 (63.2) 297.1 (66.2) 0.114
Hand Function – DASH
Question 1 2.8 (12.6) 1.6 (5.7) 0.6 (2.8) 1.6 (5.7) 2.8 (12.6) 3.1 (10.4) 0.524 2.2 (9.8) 2.5 (6.8) 0.689
Question 2 15.0 (20.4) 22.8 (28.0) 15.0 (18.9) 20.3 (25.1) 13.7 (17.5) 19.4 (26.3) 0.893 16.2 (17.5) 15.3 (26.0) 0.459
Question 3 42.0 (18.4) 39.1 (16.9) 34.4 (14.5) 31.8 (17.6) 35.3 (13.2) 28.6 (18.0) 0.382 32.2 (11.1) 22.0 (20.0) 0.225
Data are reported as mean (standard deviation); SG: study group; CG: control group; T0: baseline; T45: 45 days from baseline; T90: 90 days from 
baseline; T180: 180 days from baseline; VAS: visual analogue scale; DASH: Disabilities of the Arm, Shoulder and Hand questionnaire; Kgf: kilogram 
force; p1: p-value between SG and CG groups over time (T0–T90) using ANOVA; p2: p-value between SG and CG groups at each time using t-test; 
p3: p-value between SG and CG groups over time (T90–T180) using ANOVA.
*Significant p-value.
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daily living. This demonstrates the effectiveness of the splint 
in controlling pain related to OA of the TMC. 
Rannou et al. (22) found similar results regarding pain among 
patients with OA of the TMC joint; however, this benefit was 
observed only after 12 months and the assessor of this trial 
was not blinded. An RCT published in 2004 also found a 
decrease on pain, but since the patients in both groups wore a 
splint and did exercise, it is difficult to say whether this result 
occurred due to the splint or the exercises (22). Nicholas et 
al. (28) found a similar result regarding pain, reporting that 
immobilization of the hands with the use of a splint provided 
a reduction in inflammation of the finger joints and concluding 
that patients obtain this reduction in pain depending on the 
duration of splint use; however, the study was not a controlled 
study. Another study proposing conservative treatment with 
the use of a splint as an alternative for patients with OA of the 
TMC joint de monstrated the benefit of splints in the reduc-
tion of the severity of symptoms, allowing patients to return 
to normal functions without significant pain. Unfortunately, 
this study was also not a controlled study, only employed one 
assessment instrument and had a short intervention time of 
just 3–4 weeks (29).
Despite the improvement in pain, the patients had no im-
provement in function, which was surprising, as we believed 
that function would improve with the reduction in pain. How-
ever, the DASH scores revealed no differences between groups, 
thereby demonstrating that the patients had no improvement in 
functional capacity. Upon analysing our results, we perceived 
that the DASH scores for both groups diminished and the im-
provement tended to be greater in the SG, despite not being 
statistically significant. We believe this may have occurred 
due to the fact that the patients did not exhibit an expressive 
functional loss at the initial evaluation (DASH scores indicated 
moderate disability). It is perhaps for this reason that no im-
provement in function was observed. Another consideration 
regarding the lack of effect measured by DASH is that this 
instrument has a number of items that are not specific to hand 
use or particularly the use of the thumb; thus, responsiveness 
for this particular purpose could be limited.
Regarding grip and pinch strength, we initially believed 
that the splint would stabilize the thumb, thereby improving 
strength and the reduction in pain would benefit this parameter 
as well, but we also feared that immobilization could lead to 
muscle atrophy and a reduction in strength. However, we ob-
served no changes in palmar grip strength or tip pinch strength 
with the use of the splint. Therefore, the splint can be used 
without a loss of strength, even though its main function is 
the stabilization of the TMC joint during the performance of 
activities of daily living. With regard to key pinch strength, the 
splint led to reduced strength in both the SG and CG. 
Caporrino (30) found mean palmar grip strength of 44.2 
Kgf and 40.5 Kgf on the dominant and non-dominant side of 
healthy males, respectively, and 31.6 Kgf and 28.4 Kgf on the 
dominant and non-dominant side of healthy females, respec-
tively. In the present study, we found lower means, consistent 
with those among patients with RA. Mean tip pinch strength 
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pinch strength is 9.9 Kgf for males and 6.7 Kgf for females in 
the normal population (13). The means found in the present 
study were lower for both types of pinch strength, but also 
consistent with those among patients with RA.
No statistically significant difference was found between 
groups regarding manual dexterity. However, the patients in 
the SG had a shorter performance time on the O’Connor test 
with the use of the splint. We can therefore state that the use 
of a splint for OA of the TMC on this test, in which there are 
a greater number of repeated movements, offered protection 
to the TMC joint.
The discussion is hampered by the lack of publications with 
methodological quality on this subject. Very few articles have 
been published that scientifically report the use of a splint on 
OA of the TMC joint.
The present study had an uncommon design for a RCT, but 
it could help analyse better the effectiveness of splint use, as 
comparisons could be made with the control group, which did 
not use the splint the first 90 days, and further comparisons 
could be made between the group that used the splint for 180 
days and the group that used it for 90 days to determine whether 
there was further improvement in the former after the first 90 
days of splint use.
There were some limitations to the present study that should 
be addressed. The results cannot be extrapolated to other 
populations, as nearly all the participants were female. Data 
on compliance/adherence, side-effects and patients’ opinion 
of the splints were not assessed and blinding the patients was 
not possible. 
The use of a splint during activities of daily living for pa-
tients with OA of the TCM joint in the dominant hand reduces 
pain in both the short and long term. Splint use does not change 
the final result of grip strength or tip pinch strength; nor does 
it have a great impact on functional capacity. It does, however, 
reduce key pinch strength during use. 
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